Supplementary Table 3 from Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
OS Multivariate analysis showing that markers significant during univariate analysis are not significant during multivariate analysis.
创建时间：
2024-07-15
